Soft Gel awarded patent for skin product

Soft Gel has been awarded a US patent (6,806,259) for its Injuv soft gelatin capsule, a skincare supplement aimed at improving skin texture and appearance.

Injuv is a low molecular weight hyaluronic acid (HA) cosmeceutical that is extracted from rooster combs.

It works through an enzyme-cleaving process that reduces hyaluronic acid into lower molecular weight polymers that can then be absorbed when taken orally. However, the chemical composition of the HA remains unchaged. The patented process to alter HA's weight was developed in Japan.

Hyaluronic acid is a high molecular weight glycosaminoglycan, like chondroitin sulphate, and it is now known to be present in large quantities in the extracellular matrix, trapping huge amounts of water in the skin, connective tissue and cartilage.

"We have just completed a clinical trial with an Injuv formulation, and the results on improving skin appearance and texture were considered significant by the researchers," said Ron Udell, president of Soft Gel.

Clinical trials have also demonstrated its significant benefit to wound healing, although its greatest potential is no doubt in anti-ageing skincare supplements.

The Los Angeles-based company introduced the product as a supplement into the US last year, though it has been used for some years by the medical community in injectable form to help prevent pain in knee osteoarthritis

The ingredient could also be used in foods.

The most recent US product launch by Soft Gel was that of WasabiSol - a detoxification and immune support supplement - in October at SupplySide West.

Wasabia japonica - or Japanese horseradish - is a potent source of long chain isothiocyanates - natural compounds found in foods such as broccoli, cabbage and watercress - which support phase I and phase II detoxification in the liver and promote certain immune functions. It has also been suggested that the active ingredients in these foods may increase bone density.